If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 51 - 60 of 275
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Objective
Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Protocol No
CVC-BOSTONSCIENTIFIC-ACURATE
Categories
A Phase 3, Multi-center, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Objective
Aficamten v Placebo in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Protocol No
CVC-CYTOKINETICS-CY6033
Categories
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Objective
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Protocol No
CVC-IIT-BEYERS-AMF-T2DM
Categories
REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Objective
REACT-AF Monitoring AFib
Protocol No
CVC-JH-REACT-AF
Categories
Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)
Objective
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Protocol No
CVC-NHLBI-REBIRTH
Categories
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial
Objective
Revascularization Choices Among under-Represented Groups Evaluation
Protocol No
CVC-PCORI-RECHARGE-M
Categories
Cerebral Protection in Transcatheter Aortic Valve Replacement: The PROTEMBO Trial
Objective
Cerebral Protection in Transcatheter Aortic Valve Replacement
Protocol No
CVC-PROTEMBIS-PROTEMBO
Categories
A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas
Objective
Study of immunotherapy + chemo for patients with aggressive poorly differentiated sarcomas
Protocol No
ECOG-EA7222
Brain Oxygen Optimization in Severe TBI (BOOST3): A Comparative Effectiveness Study to Test the Efficacy of a Prescribed Treatment Protocol Based on Monitoring the Partial Pressure of Brain Tissue Oxygen
Objective
Brain Oxygen Optimization in Severe TBI
Protocol No
EM-NINDS-BOOST3
Categories
A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Patients With Partial Lipodystrophy
Objective
Daily Subcutaneous Metreleptin Treatment in Patients With FPLD
Protocol No
ENDO-AMRYT-APG-20
Categories